Some tuberculosis program managers report double-digit increases, and the cost of antibiotics to treat it is rising.

A single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens according to the findings of a new phase 3 clinical trial, published in The Lancet. The study was ...

ImmunityBio, Inc. (NYSE: IBRX), a commercial stage immunotherapy company developing next generation therapies that drive immunological memory and restore immune competence, today announced that the ...

It assessed the cost-effectiveness of the shorter bedaquiline-based regimens -- BPaL (bedaquiline, pretomanid and linezolid) and BPaLM (with moxifloxacin) -- in comparison with the nine-to-11-month ...

A six-month, all-oral treatment for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) is more cost-effective and delivers better health outcomes than the longer regimens currently ...

NEW DELHI: A shorter, six‑month and all‑oral treatment regimens for multidrug‑resistant and rifampicin‑resistant tuberculosis (MDR/RR‑TB) are cost‑effective and deliver better health outcomes than ...

Health workers in developing countries know that isolating tuberculosis patients is an outdated and potentially harmful practice, but lack the resources to move away from it. By Stephanie Nolen ...

BUFFALO, N.Y. – Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new inhalable form of tuberculosis (TB) treatment that could ...

Antimicrobial stewardship (AMS) refers to coordinated strategies for the targeted, evidence-based, and safe use of anti-infective agents. The aim is to improve treatment outcomes, minimize side ...

Xpert MTB/RIF Ultra is a rapid test that probably reduces the time taken to diagnose tuberculosis (TB) and the time from diagnosis to starting treatment. Using Xpert MTB/RIF Ultra does not reduce ...